{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:18:38Z","timestamp":1792268318912,"version":"4.4.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/aog.0000000000000386","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T23:09:55Z","timestamp":1404860995000},"page":"233-241","source":"Crossref","is-referenced-by-count":36,"title":["Sexual Function in Women on Estradiol or Venlafaxine for Hot Flushes"],"prefix":"10.1097","volume":"124","author":[{"given":"Susan D.","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadine","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"Shifren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen W.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Z.","family":"LaCroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210126","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/gme.0b013e3181948dd0","article-title":". Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Womens Health Across the Nation.","volume":"16","author":"Avis","year":"2009","journal-title":"Menopause"},{"key":"R2-6-20210126","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/gme.0b013e3181a3cdaf","article-title":". Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Womens Health Across the Nation.","volume":"16","author":"Avis","year":"2009","journal-title":"Menopause"},{"key":"R3-6-20210126","first-page":"456","article-title":"Are changes in sexual functioning during midlife due to aging or menopause Fertil S","volume":"76","author":"Dennerstein","year":"2001","journal-title":"teril"},{"key":"R4-6-20210126","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/j.1743-6109.2008.00936.x","article-title":"Sexual function, dysfunction, and sexual distress in a prospective, population-based sample of mid-aged, Australian-born women.","volume":"5","author":"Dennerstein","year":"2008","journal-title":"J Sex Med"},{"key":"R5-6-20210126","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/01.AOG.0000258781.15142.0d","article-title":"Hormones and sexuality during transition to menopause.","volume":"109","author":"Gracia","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R7-6-20210126","first-page":"823","article-title":"Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.","volume":"102","author":"Speroff","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R8-6-20210126","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/13697130902748967","article-title":"Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.","volume":"12","author":"Haines","year":"2009","journal-title":"Climacteric"},{"key":"R9-6-20210126","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3109\/00016349309021160","article-title":"Is sexual life influenced by transdermal estrogen therapy A double blind placebo controlled study in postmenopausal women.","volume":"72","author":"Nathorst-Boos","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R10-6-20210126","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2005.04.003","article-title":"Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study.","volume":"53","author":"Nielsen","year":"2006","journal-title":"Maturitas"},{"key":"R11-6-20210126","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/gme.0b013e31803867a","article-title":"A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women.","volume":"14","author":"Shifren","year":"2007","journal-title":"Menopause"},{"key":"R12-6-20210126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e318265df42","article-title":"A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.","volume":"120","author":"Sprague","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R13-6-20210126","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":". Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"R14-6-20210126","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/JCP.0b013e3181a5233f","article-title":"Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.","volume":"29","author":"Serretti","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R15-6-20210126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2005.12.007","article-title":"Burden of phase-specific sexual dysfunction with SSRIs.","volume":"91","author":"Clayton","year":"2006","journal-title":"J Affect Disord"},{"key":"R16-6-20210126","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/JCP.0b013e318172b48c","article-title":"A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.","volume":"28","author":"Kennedy","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R17-6-20210126","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/070674370204700208","article-title":"Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.","volume":"47","author":"Vanderkooy","year":"2002","journal-title":"Can J Psychiatry"},{"key":"R18-6-20210126","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/01.jcp.0000239790.83707.ab","article-title":"A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R19-6-20210126","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4088\/JCP.v63n0414","article-title":". Prevalence of sexual dysfunction among newer antidepressants.","volume":"63","author":"Clayton","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R20-6-20210126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R21-6-20210126","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":". Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"R22-6-20210126","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1634\/theoncologist.12-1-124","article-title":". Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.","volume":"12","author":"Carpenter","year":"2007","journal-title":"Oncologist"},{"key":"R23-6-20210126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/GME.0b013e31829337a4","article-title":". Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network.","volume":"21","author":"Newton","year":"2013","journal-title":"Menopause"},{"key":"R25-6-20210126","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":". The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"R26-6-20210126","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/AOG.0b013e3182475fa4","article-title":"Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trial.","volume":"119","author":"Reed","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R27-6-20210126","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-144-10-200605160-00005","article-title":"; Diagnostic Aspects of Incontinence Study (DAISy) Research Group. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence.","volume":"144","author":"Brown","year":"2006","journal-title":"Ann Intern Med"},{"key":"R28-6-20210126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0378-5122(96)01038-9","article-title":". A menopause-specific quality of life questionnaire: development and psychometric properties.","volume":"24","author":"Hilditch","year":"1996","journal-title":"Maturitas"},{"key":"R29-6-20210126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.2010.2016","article-title":". Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.","volume":"305","author":"Freeman","year":"2011","journal-title":"JAMA"},{"key":"R30-6-20210126","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/01.wnl.0000277275.42504.93","article-title":"Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.","volume":"69","author":"Maki","year":"2007","journal-title":"Neurology"},{"key":"R31-6-20210126","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13697130008500107","article-title":"Low-dose esterified estrogens (0.3 mgday): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.","volume":"3","author":"Rebar","year":"2000","journal-title":"Climacteric"},{"key":"R32-6-20210126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/WHE.12.69","article-title":"The Kronos Early Estrogen Prevention Study by Charlotte Barker.","volume":"9","author":"Manson","year":"2013","journal-title":"Womens Health (Lond Engl)"},{"key":"R33-6-20210126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ajog.2006.05.056","article-title":"Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.","volume":"196","author":"Rapkin","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R34-6-20210126","first-page":"172","article-title":"A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.","volume":"200","author":"Archer","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R35-6-20210126","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.2009.26.6379","article-title":". Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes; NCCTG trial N05C9.","volume":"28","author":"Barton","year":"2010","journal-title":"J Clin Oncol"},{"key":"R36-6-20210126","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.gme.0000196595.82452.ca","article-title":"Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population.","volume":"13","author":"Gordon","year":"2006","journal-title":"Menopause"},{"key":"R37-6-20210126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.gme.0000243571.55699.4a","article-title":"Efficacy of citalopram on climacteric symptoms.","volume":"14","author":"Kalay","year":"2007","journal-title":"Menopause"},{"key":"R38-6-20210126","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.gme.0000240633.46300.fa","article-title":". Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.","volume":"13","author":"Soares","year":"2006","journal-title":"Menopause"},{"key":"R39-6-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000297371.89129.b3","article-title":"Olivier S; Study 315 Investigators. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.","volume":"111","author":"Speroff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R40-6-20210126","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2036.2011.04978.x","article-title":"Systematic review: the treatment of noncardiac chest pain with antidepressants.","volume":"35","author":"Nguyen","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R41-6-20210126","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/AJP.0b013e318243075c","article-title":"Painful diabetic polyneuropathy: approach to diagnosis and management.","volume":"28","author":"Spallone","year":"2012","journal-title":"Clin J Pain"},{"key":"R42-6-20210126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin.","volume":"60","author":"Berger","year":"2009","journal-title":"Annu Rev Med"},{"key":"R43-6-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores.","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"R44-6-20210126","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/GME.0b013e3182a66aa7","article-title":". Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T17:07:01Z","timestamp":1649610421000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201408000-00006"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000386","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}